-
Loading metrics
Efficacy and safety of T-DXd versus Other HER2-targeted therapies in second-line and later settings for HER2-positive metastatic breast cancer: A Bayesian network meta-analysis
- Yu Xiao,
- Jing Fu,
- Juan Li,
- Gang Hu
x
- Published: September 29, 2026
- https://doi.org/10.1371/journal.pone.0358540